An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Because of a previous association of pseudotumor cerebri (PTC) with levonorgestrel, we wished to evaluate the use of levonorgestrel-eluting intrauterine devices (“levonorgestrel intrauterine systems”, LNG-IUS) in our University of Utah and Rigshospitalet PTC patients. In our retrospective series, PTC prevalence was approximately 0.18% and 0.15% in the LNG-IUS population versus 0.02% and 0.04% in the non-LNG-IUS population (Utah and Rigshospitalet, respectively), with no significant differences in PTC signs and symptoms among the two groups. Our investigation suggests that women with an LNG-IUS may have increased risk of developing PTC but does not suggest an LNG-IUS can cause PTC.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Neuro-Ophthalmology |
Vol/bind | 41 |
Udgave nummer | 4 |
Sider (fra-til) | 192-197 |
Antal sider | 6 |
ISSN | 0165-8107 |
DOI | |
Status | Udgivet - 2017 |
Links
- http://europepmc.org/articles/pmc5762147
Forlagets udgivne version
ID: 197005086